Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondroma
- 24 May 2006
- journal article
- research article
- Published by Wiley in Proteomics
- Vol. 6 (11), 3426-3435
- https://doi.org/10.1002/pmic.200500472
Abstract
Osteosarcoma (OS) is the most common malignant bone tumor in children. To identify a plasma proteomic signature that can detect OS, we used SELDI MS to perform proteomic profiling on plasma specimens from 29 OS and 20 age-matched osteochondroma (OC) patients. Nineteen statistically significant ion peaks that were differentially expressed in OS when compared with OC patients were identified (p < 0.001 and false discovery rate < 10%). Using the proteomic profiles, we constructed a multivariate 3-nearest neighbors classifier to distinguish OS from OC patients with a sensitivity of 97% and a specificity of 80% based on external leave-one-out crossvalidation. Permutation test showed that the classification result was statistically significant (p < 0.00005). One of the proteins (m/z 11 704) in the proteomic signature was identified as serum amyloid protein A (SAA) by PMF. The higher plasma level of SAA in OS patients was further validated by Western blotting when compared to that of osteochrondroma patients and normal subjects as reference. The classifier based on this plasma proteomic signature may be useful to differentiate malignant bone cancer from benign bone tumors and for early detection of OS in high-risk individuals.Keywords
This publication has 36 references indexed in Scilit:
- Expression Profiles of Osteosarcoma That Can Predict Response to ChemotherapyCancer Research, 2005
- HUPO Plasma Proteome Project specimen collection and handling: Towards the standardization of parameters for plasma proteome samplesProteomics, 2005
- Identification of Serum Amyloid A as a Biomarker to Distinguish Prostate Cancer Patients with Bone LesionsClinical Chemistry, 2005
- Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian CancerCancer Research, 2004
- Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patientsLaboratory Investigation, 2004
- Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experimentsBioinformatics, 2004
- Current developments in SELDI affinity technologyMass Spectrometry Reviews, 2003
- A Paradigm for Class Prediction Using Gene Expression ProfilesJournal of Computational Biology, 2002
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences of the United States of America, 2001
- Probability-based protein identification by searching sequence databases using mass spectrometry dataElectrophoresis, 1999